Clinical trial
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic…
NCT00116428 · Biosense Webster, Inc., Industry · Completed
Key facts
| NCT number | NCT00116428 |
|---|---|
| Title | NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation |
| Official title | NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation |
| Acronym | Afib IDE |
| Lead sponsor | Biosense Webster, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Diseases, Arrhythmia, Atrial Fibrillation |
| Intervention type | Device, Drug |
| Interventions | NAVISTAR® THERMOCOOL® Catheter, Antiarrhythmic drug |
| Enrollment | 167 |
| Start date | Oct 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Mar 1, 2011 |
| First posted | Jun 30, 2005 |
| Last update posted | Oct 24, 2017 |
| Countries | Brazil, Canada, Czechia, Italy, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 10–99 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: